6505--Imatinib Tablets

The VA and DoD are seeking a prime vendor to supply imatinib mesylate tablets (100 mg in 90‑tablet bottles and 400 mg in 30‑tablet bottles) for distribution through their Pharmaceutical Prime‑Vendor programs. The contract is a firm‑fixed‑price, indefinite‑delivery, requirements contract with a base year and up to four one‑year options, totaling a possible five‑year ordering period. Offerors must provide unique NDC numbers, FDA‑approved products, compliant packaging, bar‑coding, and a 0.5 % cost‑recovery fee, along with a subcontracting plan if the award exceeds $900 k. The award will be made to the lowest evaluated price that meets all technical requirements. • Supplies: Imatinib 100 mg (90 tablets/bottle) – approx. 6,400 bottles annually; Imatinib 400 mg (30 tablets/bottle) – approx. 19,500 bottles annually. • Requirements: FDA‑approved, cGMP‑compliant manufacturing, specific bottle dimensions, safety caps, linear GS1‑128 bar‑code, DSCSA serialization, and immediate recall notification. • Contract terms: Firm‑fixed‑price, base year + up to four optional years, quarterly sales‑reporting with 0.5 % CRF, and mandatory subcontracting‑plan submission for large‑business offers.